Amendment SSA1-AB68

AB68-SSA1,1312,19 551.614 (2) Fees related to broker-dealers, agents, investment advisers, investment adviser representatives, and federal covered advisers. Every applicant for an initial or renewal license under s. 551.401, 551.402, 551.403, or 551.404 shall pay a filing fee of $200 $300 in the case of a broker-dealer or investment adviser and $80 $100 in the case of an agent representing a broker-dealer or issuer or an investment adviser representative, except that, in the case of an agent representing a broker-dealer or issuer or an investment adviser representative, no fee is required for an individual who is eligible for the veterans fee waiver program under s. 45.44. Every federal covered adviser in this state that is required to make a notice filing under s. 551.405 shall pay an initial or renewal notice filing fee of $200 $300. A broker-dealer, investment adviser, or federal covered adviser maintaining a branch office within this state shall pay an additional filing fee of $80 $100 for each branch office. When an application is denied, or an application or a notice filing is withdrawn, the filing fee shall be retained.

AB68-SSA1,2938 Section 2938. 563.055 (6) of the statutes is amended to read:

AB68-SSA1,1312,22 563.055 (6) All moneys received under this section shall be credited to the appropriation account under s. 20.505 (8) (jm) (jn).

AB68-SSA1,2939 Section 2939. 563.13 (4) of the statutes is amended to read:

AB68-SSA1,1313,2 563.13 (4) A $10 license fee for each bingo occasion proposed to be conducted and $5 for an annual license for the designated member responsible for the proper utilization of gross receipts. All moneys received under this subsection shall be credited to the appropriation account under s. 20.505 (8) (jm) (jn).

AB68-SSA1,2940 Section 2940. 563.135 (2m) of the statutes is amended to read:

AB68-SSA1,1313,5 563.135 (2m) All moneys received under sub. (1) shall be credited to the appropriation account under s. 20.505 (8) (jm) (jn).

AB68-SSA1,2941 Section 2941. 563.16 of the statutes is amended to read:

AB68-SSA1,1313,18 563.16 Amendment of license to conduct bingo. Upon application by a licensed organization, a license may be amended, if the subject matter of the amendment properly and lawfully could have been included in the original license. An application for an amendment to a license shall be filed and processed in the same manner as an original application. An application for the amendment of a license shall be accompanied by a $3 fee. If any application for amendment seeks approval of additional bingo occasions or designates a new member responsible for the proper utilization of gross receipts, the appropriate fee under s. 563.13 (4) also shall be paid. If the department approves an application for an amendment to a license, a copy of the amendment shall be sent to the applicant who shall attach it to the original license. All moneys received under this section shall be credited to the appropriation account under s. 20.505 (8) (jm) (jn).

AB68-SSA1,2942 Section 2942. 563.22 (2) (c) of the statutes is amended to read:

AB68-SSA1,1313,21 563.22 (2) (c) All moneys received under this subsection shall be credited to the appropriation account under s. 20.505 (8) (jm) (jn).

AB68-SSA1,2943 Section 2943. 563.80 (2m) of the statutes is amended to read:

AB68-SSA1,1313,24 563.80 (2m) All moneys received under sub. (1) shall be credited to the appropriation account under s. 20.505 (8) (jm) (jn).

AB68-SSA1,2944 Section 2944. 563.92 (2) of the statutes is amended to read:

AB68-SSA1,1314,10 563.92 (2) The fee for a raffle license shall be $25 and shall be remitted with the application. A raffle license shall be valid for 12 months and may be renewed as provided in s. 563.98 (1g). The department shall issue the license within 30 days after the filing of a complete application if the applicant qualifies under s. 563.907 and has not exceeded the limits of s. 563.91. The department shall notify the applicant within 15 days after it is filed if the raffle license application is incomplete or the application shall be considered complete. A complete license application that is not denied within 30 days after its filing shall be considered approved. All moneys received by the department under this subsection shall be credited to the appropriation account under s. 20.505 (8) (j) (jn).

AB68-SSA1,2945 Section 2945. 563.98 (1g) of the statutes is amended to read:

AB68-SSA1,1314,14 563.98 (1g) An organization licensed under this subchapter may renew the license by submitting a $25 renewal fee. All moneys received under this subsection shall be credited to the appropriation account under s. 20.505 (8) (j) (jn).

AB68-SSA1,2946 Section 2946. 601.31 (1) (mv) of the statutes is created to read:

AB68-SSA1,1314,18 601.31 (1) (mv) For initial licensure and renewal of licensure for pharmacy benefit management brokers and consultants, amounts set by the commissioner by rule.

AB68-SSA1,2947 Section 2947. 601.31 (1) (nv) of the statutes is created to read:

AB68-SSA1,1314,21 601.31 (1) (nv) For issuing or renewing a license to a pharmaceutical representative under s. 632.863, an amount to be set by the commissioner by rule.

AB68-SSA1,2948 Section 2948 . 601.31 (1) (nw) of the statutes is created to read:

AB68-SSA1,1314,25 601.31 (1) (nw) For issuing or renewing a license to a pharmacy services administrative organization under s. 632.864, an amount to be set by the commissioner by rule.

AB68-SSA1,2949 Section 2949. 601.31 (1) (w) of the statutes is amended to read:

AB68-SSA1,1315,3 601.31 (1) (w) For initial issuance and for each annual renewal of a license as an administrator or pharmacy benefit manager under ch. 633, $100.

AB68-SSA1,2950 Section 2950 . 601.41 (12) of the statutes is created to read:

AB68-SSA1,1315,9 601.41 (12) Employee misclassification outreach and education. The commissioner shall, on at least an annual basis, conduct outreach and education to persons subject to regulation under chs. 600 to 655 on how to identify the misclassification of employees as independent contractors and how to report suspected misclassifications to the appropriate federal and state agencies.

AB68-SSA1,2951 Section 2951. 601.41 (13) of the statutes is created to read:

AB68-SSA1,1315,16 601.41 (13) Value-based diabetes medication pilot project. The commissioner shall develop a pilot project to direct a pharmacy benefit manager, as defined in s. 632.865 (1) (c), and a pharmaceutical manufacturer to create a value-based, sole-source arrangement to reduce the costs of prescription medication used to treat diabetes. The commissioner may promulgate rules to implement this subsection.

AB68-SSA1,2952 Section 2952 . 601.415 (3) of the statutes is repealed.

AB68-SSA1,2953 Section 2953. 601.415 (14) of the statutes is created to read:

AB68-SSA1,1315,24 601.415 (14) Patient pharmacy benefits tool. (a) From the appropriation under s. 20.145 (1) (a), beginning in the 2022-23 fiscal year, the office shall award grants in a total amount of up to $500,000 each fiscal year to health care providers to develop and implement a tool for prescribers to disclose the cost of prescription drugs for patients. The tool must be usable by physicians and other prescribers to determine the cost of prescription drugs for their patients.

AB68-SSA1,1316,2 (b) Any health care provider that receives a grant under par. (a) shall contribute matching funds equal to at least 50 percent of the grant amount awarded.

AB68-SSA1,2954 Section 2954 . 601.46 (3) (b) of the statutes is amended to read:

AB68-SSA1,1316,6 601.46 (3) (b) A general review of the insurance business in this state, including a report on emerging regulatory problems, developments and trends , including trends related to prescription drugs;

AB68-SSA1,2955 Section 2955. 601.575 of the statutes is created to read:

AB68-SSA1,1316,13 601.575 Prescription drug importation program. (1) Importation program requirements. The commissioner, in consultation with persons interested in the sale and pricing of prescription drugs and appropriate officials and agencies of the federal government, shall design and implement a prescription drug importation program for the benefit of residents of this state, that generates savings for residents, and that satisfies all of the following:

AB68-SSA1,1316,16 (a) The commissioner shall designate a state agency to become a licensed wholesale distributor or to contract with a licensed wholesale distributor and shall seek federal certification and approval to import prescription drugs.

AB68-SSA1,1316,19 (b) The prescription drug importation program under this section shall comply with relevant requirements of 21 USC 384, including safety and cost savings requirements.

AB68-SSA1,1316,22 (c) The prescription drug importation program under this section shall import prescription drugs from Canadian suppliers regulated under any appropriate Canadian or provincial laws.

AB68-SSA1,1316,25 (d) The prescription drug importation program under this section shall have a process to sample the purity, chemical composition, and potency of imported prescription drugs.

AB68-SSA1,1317,4 (e) The prescription drug importation program under this section shall import only those prescription drugs for which importation creates substantial savings for residents of the state and only those prescription drugs that are not brand-name drugs and that have fewer than 4 competitor prescription drugs in the United States.

AB68-SSA1,1317,7 (f) The commissioner shall ensure that prescription drugs imported under the program under this section are not distributed, dispensed, or sold outside of the state.

AB68-SSA1,1317,9 (g) The prescription drug importation program under this section shall ensure all of the following:

AB68-SSA1,1317,11 1. Participation by any pharmacy or health care provider in the program is voluntary.

AB68-SSA1,1317,13 2. Any pharmacy or health care provider participating in the program has the appropriate license or other credential in this state.

AB68-SSA1,1317,16 3. Any pharmacy or health care provider participating in the program charges a consumer or health plan the actual acquisition cost of the imported prescription drug that is dispensed.

AB68-SSA1,1317,20 (h) The prescription drug importation program under this section shall ensure that a payment by a health plan or health insurance policy for a prescription drug imported under the program reimburses no more than the actual acquisition cost of the imported prescription drug that is dispensed.

AB68-SSA1,1317,23 (i) The prescription drug importation program under this section shall ensure that any health plan or health insurance policy participating in the program does all of the following:

AB68-SSA1,1317,25 1. Maintains a formulary and claims payment system with current information on prescription drugs imported under the program.

AB68-SSA1,1318,3 2. Bases cost-sharing amounts for participants or insureds under the plan or policy on no more than the actual acquisition cost of the prescription drug imported under the program that is dispensed to the participant or insured.

AB68-SSA1,1318,6 3. Demonstrates to the commissioner or a state agency designated by the commissioner how premiums under the policy or plan are affected by savings on prescription drugs imported under the program.

AB68-SSA1,1318,9 (j) Any wholesale distributor importing prescription drugs under the program under this section shall limit its profit margin to the amount established by the commissioner or a state agency designated by the commissioner.

AB68-SSA1,1318,12 (k) The prescription drug importation program under this section may not import any generic prescription drug that would violate federal patent laws on branded products in this country.

AB68-SSA1,1318,17 (L) The prescription drug importation program under this section shall comply to the extent practical and feasible, before the prescription drug to be imported comes into the possession of the state's wholesale distributor and fully after the prescription drug to be imported is in the possession of the state's wholesale distributor, with tracking and tracing requirements of 21 USC 360eee to 360eee-1.

AB68-SSA1,1318,20 (m) The prescription drug importation program under this section shall establish a fee or other mechanism to finance the program that does not jeopardize significant savings to residents of the state.

AB68-SSA1,1318,22 (n) The prescription drug importation program under this section shall have an audit function that ensures all of the following:

AB68-SSA1,1318,25 1. The commissioner has a sound methodology to determine the most cost-effective prescription drugs to include in the importation program under this section.

AB68-SSA1,1319,2 2. The commissioner has a process in place to select Canadian suppliers that are high quality, high performing, and in full compliance with Canadian laws.

AB68-SSA1,1319,4 3. Prescription drugs imported under the program are pure, unadulterated, potent, and safe.

AB68-SSA1,1319,6 4. The prescription drug importation program is complying with the requirements of this subsection.

AB68-SSA1,1319,9 5. The prescription drug importation program under this section is adequately financed to support administrative functions of the program while generating significant cost savings to residents of the state.

AB68-SSA1,1319,11 6. The prescription drug importation program under this section does not put residents of the state at a higher risk than if the program did not exist.

AB68-SSA1,1319,13 7. The prescription drug importation program under this section provides and is projected to continue to provide substantial cost savings to residents of the state.

AB68-SSA1,1319,16 (2) Anticompetitive behavior. The commissioner, in consultation with the attorney general, shall identify the potential for and monitor anticompetitive behavior in industries affected by a prescription drug importation program.

AB68-SSA1,1320,2 (3) Approval of program design; certification. No later than the first day of the 7th month beginning after the effective date of this subsection .... [LRB inserts date], the commissioner shall submit to the joint committee on finance a report that includes the design of the prescription drug importation program in accordance with this section. The commissioner may not submit the proposed prescription drug importation program to the federal department of health and human services unless the joint committee on finance approves the proposed prescription drug implementation program. Within 14 days of the date of approval by the joint committee on finance of the proposed prescription drug importation program, the commissioner shall submit to the federal department of health and human services a request for certification of the approved prescription drug importation program.

AB68-SSA1,1320,10 (4) Implementation of certified program. After the federal department of health and human services certifies the prescription drug importation program submitted under sub. (3), the commissioner shall begin implementation of the program, and the program shall be fully operational by 180 days after the date of certification by the federal department of health and human services. The commissioner shall do all of the following to implement the prescription drug importation program to the extent the action is in accordance with other state laws and the certification by the federal department of health and human services:

AB68-SSA1,1320,13 (a) Become a licensed wholesale distributor, designate another state agency to become a licensed wholesale distributor, or contract with a licensed wholesale distributor.

AB68-SSA1,1320,15 (b) Contract with one or more Canadian suppliers that meet the criteria in sub. (1) (c) and (n).

AB68-SSA1,1320,19 (c) Create an outreach and marketing plan to communicate with and provide information to health plans and health insurance policies, employers, pharmacies, health care providers, and residents of the state on participating in the prescription drug importation program.

AB68-SSA1,1320,22 (d) Develop and implement a registration process for health plans and health insurance policies, pharmacies, and health care providers interested in participating in the prescription drug importation program.

AB68-SSA1,1320,24 (e) Create a publicly accessible source for listing prices of prescription drugs imported under the program.

AB68-SSA1,1321,3 (f) Create, publicize, and implement a method of communication to promptly answer questions from and address the needs of persons affected by the implementation of the program before the program is fully operational.

AB68-SSA1,1321,5 (g) Establish the audit functions under sub. (1) (n) with a timeline to complete each audit function every 2 years.

AB68-SSA1,1321,8 (h) Conduct any other activities determined by the commissioner to be important to successful implementation of the prescription drug importation program under this section.

AB68-SSA1,1321,10 (5) Report. By January 1 and July 1 of each year, the commissioner shall submit to the joint committee on finance a report including all of the following:

AB68-SSA1,1321,12 (a) A list of prescription drugs included in the importation program under this section.

AB68-SSA1,1321,15 (b) The number of pharmacies, health care providers, and health plans and health insurance policies participating in the prescription drug importation program under this section.

AB68-SSA1,1321,20 (c) The estimated amount of savings to residents of the state, health plans and health insurance policies, and employers resulting from the implementation of the prescription drug importation program under this section reported from the date of the previous report under this subsection and from the date the program was fully operational.

AB68-SSA1,1321,22 (d) Findings of any audit functions under sub. (1) (n) completed since the date of the previous report under this subsection.

AB68-SSA1,1321,24 (6) Rulemaking. The commissioner may promulgate any rules necessary to implement this section.

AB68-SSA1,2956 Section 2956. 601.59 of the statutes is created to read:

AB68-SSA1,1322,1 601.59 State-based exchange. (1) Definitions. In this section:

AB68-SSA1,1322,2 (a) “Exchange” has the meaning given in 45 CFR 155.20.

AB68-SSA1,1322,5 (b) “State-based exchange on the federal platform” means an exchange that is described in and meets the requirements of 45 CFR 155.200 (f) and is approved by the federal secretary of health and human services under 45 CFR 155.106.

AB68-SSA1,1322,9 (c) “State-based exchange without the federal platform” means an exchange, other than one described in 45 CFR 155.200 (f), that performs all the functions described in 45 CFR 155.200 (a) and is approved by the federal secretary of health and human services under 45 CFR 155.106.

AB68-SSA1,1322,16 (2) Establishment and operation of state-based exchange. The commissioner shall establish and operate an exchange that at first is a state-based exchange on the federal platform and then subsequently transitions to a state-based exchange without the federal platform. The commissioner shall develop procedures to address the transition from the state-based exchange on the federal platform to the state-based exchange without the federal platform, including the circumstances that shall be met in order for the transition to occur.

AB68-SSA1,1322,19 (3) Agreement with federal government. The commissioner may enter into any agreement with the federal government necessary to facilitate the implementation of this section.

AB68-SSA1,1322,25 (4) User fees. The commissioner shall impose a user fee, as authorized under 45 CFR 155.160 (b) (1), on each insurer that offers a health plan through the state-based exchange on the federal platform or the state-based exchange without the federal platform. The user fee shall be applied at one of the following rates on the total monthly premiums charged by an insurer for each policy under the plan where enrollment is through the exchange: